Use of Molecular Tumour Markers to Improve Diagnostic Performance of Bronchoscopy in Assessment of Pulmonary Nodules and Early Diagnosis of Lung Cancer
Grant number: 1121880 | Funding period: 2017 - 2020
Completed
Abstract
Pulmonary nodules may represent early lung cancer though difficulty in accurate diagnosis means many patients experience delayed diagnosis, or unnecessary surgical biopsy or repeat CT imaging (& consequent radiation exposure). I will identify molecular (DNA, protein) markers in bronchoscopic & blood specimens to accurately characterize malignant & benign nodules. These biomarkers will also be investigated for their value as a non-invasive screening test for lung cancer